EX-FILING FEES 11 ex-107.htm

 

Exhibit 107

Calculation of Filing Fee Tables

Form S-1

(Form Type)

OncoSec Medical Incorporated

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered Securities

 

   Security
Type
  Security Class Title(1)  Fee Calculation or
Carry Forward
Rule
  Amount
Registered
  Proposed Maximum
Offering Price Per
Unit
  Proposed
Maximum
Aggregate
Offering
Price(1)
  Fee Rate  Amount of
Registration
Fee
Newly Registered Securities
Fees to be Paid                                  
                                   

Fees

Previously Paid

  Equity 

Common Stock, $0.0001 par value per share(2)(3)

  Rule 457(o)            $

7,500,000

   $

0.00011020

   $

826.5

 
   Equity 

Common Stock Underlying Pre-Funded Warrants(3)(4)

 

Rule 457(o)

             

   $

0.00011020

    

 
   Equity 

Common Stock Underlying Series A Warrants(5)

  Rule 457(g)   

    

   $ 7,500,000    $

0.00011020

   $

826.5

 
    Equity   Common Stock Underlying Series B Warrants(5)   Rule 457(g)                $

7,500,000

    $ 

0.00011020

    $ 

825.6

 
                                   
Carry Forward Securities
Carry Forward Securities                                  
   Total Offering Amounts        $

22,500,000

   $0.00011020   $

2479.50

 
   Total Fees Previously Paid                   2,204 
   Total Fees Offsets                     
   Net Fee Due                  $

275.5

(6)

 

  (1) Pursuant to Rule 416 under the Securities Act, the shares registered hereby also include an indeterminate number of additional shares of common stock as may from time to time become issuable by reason of stock splits, distributions, recapitalizations or other similar transactions.
     
  (2) Estimated solely for the purpose of computing the registration fee in accordance with Rule 457(o) under the Securities Act of 1933, as amended.
     
  (3) The proposed maximum aggregate offering price of the common stock will be reduced on a dollar-for-dollar basis based on the offering price of any pre-funded warrants issued in the offering, and the proposed maximum aggregate offering price of the pre-funded warrants to be issued in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any common stock issued in the offering. Accordingly, the proposed maximum aggregate offering price of the common stock and pre-funded warrants (including the common stock issuable upon exercise of the pre-funded warrants), if any, is $10,000,000.
     
  (4) The registrant may issue pre-funded warrants to purchase common shares in the offering. The purchase price of each pre-funded warrant will equal the price per share at which shares of common shares are being sold to the public in this offering, minus $0.0001, which constitutes the pre-funded portion of the exercise price, and the remaining unpaid exercise price of the pre-funded warrant will equal $0.0001 per share (subject to adjustment as provided for therein).
     
  (5) As estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(g) under the Securities Act and based on an assumed per-share exercise price for the warrants of 100% of the public offering price of the common stock and pre-funded warrants; the proposed maximum aggregate offering price of the common stock and pre-funded warrants is $8,000,000.
     
  (6) A registration fee of $2,204 has previously been paid in connection with the initial filing of the Registration Statement, filed with the Securities and Exchange Commission on November 1, 2022. Accordingly, a $440.80 registration fee is being paid with this Amendment No. 2 to the Registration Statement.